Paul Feingold
107 posts
@pfeingold
@YaleSurgRes and @BrighamThoracic Trained, Thoracic and Foregut Surgeon at @URochesterSurg
Matterhorn Trial positive for EFS . Press release. It will be interesting to see How PCR Co related with EFS Delta of EFS And Added toxicity. FLOT Plus Durvalumab can be potentially new SOC . Looking forward to the data . @OncoAlert @OncBrothers @oncodaily
My deepest, heartfelt thanks to the students of @KECKSchool_USC and the @sgs_of_usc @USCGenSurg for this wonderful award; I only regret I was unable to accept it in person. I hope my continued service to you all embodies the spirit of this recognition in the years to come.
Scott Swanson @BrighamWomens asks, should we convert segmentectomy to lobectomy for positive intraoperative N1 nodes? If N1 nodal disease is encountered, is further surgery necessary? Find out in #JTCVS Open: doi.org/10.1016/j.xjon…
'I can't thank these people enough': Rochester becoming upstate epicenter for heart transplants - WHEC.com whec.com/top-news/i-can…
.@pfeingold et al find a 3-field MIE approach was associated w/higher rate of repeat dilations in patients undergoing MIE. Shorter interval b/w esophagectomy and initial dilation is strongly associated w/need for repeated dilations. Link below.
Millions of Americans take medications known as proton pump inhibitors every day to treat heartburn and acid reflux, and in recent years, these drugs have been linked to a greater risk of kidney failure, stroke, and early death from any cause cnn.it/47tRkJl
Congratulations to a master surgical educator, Dr. Ripley, for inspiring BCM medical students who selected him to receive a PEAR Award. We are delighted that one of our very own is making a lasting, positive impression on our next generation of change makers!
